Methotrexate-induced hemothorax in a woman with low-risk metastatic gestational trophoblastic disease | Zendy

Yuji Ohki | Zendy; Hisako Yamada | Zendy; Yusuke Taira | Zendy; Wataru Kudaka | Zendy; Yoichi Aoki | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Methotrexate-induced hemothorax in a woman with low-risk metastatic gestational trophoblastic disease

Author(s) -

Yuji Ohki,

Hisako Yamada,

Yusuke Taira,

Wataru Kudaka,

Yoichi Aoki

Publication year - 2019

Publication title -

gynecologic oncology reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.557

H-Index - 15

ISSN - 2352-5789

DOI - 10.1016/j.gore.2019.100517

Subject(s) - medicine , methotrexate , gestational trophoblastic disease , chemotherapy , vascularity , chorioepithelioma , surgery , hemothorax , radiology , pregnancy , choriocarcinoma , gestation , pneumothorax , biology , genetics

Highlights • Patients with invasive mole have a risk of bleeding to fragility and vascularity of the tumor.• Some patients may experience life-threatening bleeding.• Chemotherapy of patients with invasive/metastatic mole may induce bleeding.• In our patient with pulmonary metastatic mole, massive hemorrhage occurred 2 h after the first dose of MTX.• Our patient was successfully treated with partial resection of the bleeding tumor and additional 2 cycles of MTX.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research